Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET

被引:9
|
作者
Silva-Rudberg, Jason A. [1 ,2 ]
Salardini, Elaheh [1 ,2 ]
O'Dell, Ryan S.
Chen, Ming-Kai [3 ]
Ra, Jocelyn [1 ,2 ]
Georgelos, Jamie K. [1 ,2 ]
Morehouse, Mackenzie R. [1 ,2 ]
Melino, Kaitlyn P. [1 ,2 ]
Parma, Pradeep [3 ]
Toyonaga, Takuya [3 ]
Nabulsi, Nabeel B. [3 ]
Huang, Yiyun [3 ]
Carson, Richard E. [3 ]
van Dyck, Christopher H. [2 ,3 ]
Mecca, Adam P. [1 ,2 ,4 ]
机构
[1] Yale Univ, Alzheimers Dis Res Unit, Sch Med, New Haven, CT USA
[2] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT USA
[3] Yale Univ, Dept Radiol & Biomed Imaging, Sch Med, New Haven, CT USA
[4] Yale Univ, Alzheimers Dis Res Unit, Sch Med, One Church St,8th Floor, New Haven, CT 06510 USA
来源
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; diffusion tensor imaging; synaptic density; gray matter microstructure SV2A; positron emission tomography; VOLUME; DIFFUSIVITY; PROGRESSION; BURDEN; RISK; TAU; MCI;
D O I
10.1016/j.jagp.2023.08.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Multimodal imaging techniques have furthered our understanding of how different aspects of Alzheimer's disease (AD) pathology relate to one another. Diffusion tensor imaging (DTI) measures such as mean diffusivity (MD) may be a surrogate measure of the changes in gray matter structure associated with AD. Positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) has been used to quantify synaptic loss, which is the major pathological correlate of cognitive impairment in AD. In this study, we investigated the relationship between gray matter microstructure and syn-aptic density. Methods: DTI was used to measure MD and [11C]UCB-J PET to measure synaptic density in 33 amyloid-positive participants with AD and 17 amyloid-negative cognitively normal (CN) participants aged 50-83. Univari-ate regression analyses were used to assess the association between synaptic density and MD in both the AD and CN groups. Results: Hippocampal MD was inversely associated with hippocampal synaptic density in participants with AD (r = -0.55, p <0.001, df = 31) but not CN (r = 0.13, p = 0.62, df = 15). Explor-atory analyses across other regions known to be affected in AD suggested wide-spread inverse associations between synaptic density and MD in the AD group. Conclusion: In the setting of AD, an increase in gray matter MD is inversely asso-ciated with synaptic density. These co-occurring changes may suggest a link between synaptic loss and gray matter microstructural changes in AD. Imaging studies of gray matter microstructure and synaptic density may allow important insights into AD-related neuropathology. (Am J Geriatr Psychiatry 2024; 32:17-28)
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [21] The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
    Ellis Chika Onwordi
    Thomas Whitehurst
    Ayla Mansur
    Ben Statton
    Alaine Berry
    Marina Quinlan
    Declan P. O’Regan
    Maria Rogdaki
    Tiago Reis Marques
    Eugenii A. Rabiner
    Roger N. Gunn
    Anthony C. Vernon
    Sridhar Natesan
    Oliver D. Howes
    Translational Psychiatry, 11
  • [22] The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
    Onwordi, Ellis Chika
    Whitehurst, Thomas
    Mansur, Ayla
    Statton, Ben
    Berry, Alaine
    Quinlan, Marina
    O'Regan, Declan P.
    Rogdaki, Maria
    Marques, Tiago Reis
    Rabiner, Eugenii A.
    Gunn, Roger N.
    Vernon, Anthony C.
    Natesan, Sridhar
    Howes, Oliver D.
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [23] A Mitochondrial Role of SV2A Protein in Alzheimer's Disease: Studies with Levetiracetam
    Mueller, Walter
    Stockburger, Carola
    Friedland, Kristina
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S444 - S445
  • [24] Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains
    Mikkelsen, Jens D.
    Kaad, Sif
    Aripaka, Sanjay S.
    Finsen, Bente
    NEUROBIOLOGY OF AGING, 2023, 129 : 50 - 57
  • [25] Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging
    Nakaya, Moto
    Sato, Noriko
    Matsuda, Hiroshi
    Maikusa, Norihide
    Ota, Miho
    Shigemoto, Yoko
    Sone, Daichi
    Yamao, Tensho
    Kimura, Yukio
    Tsukamoto, Tadashi
    Yokoi, Yuma
    Sakata, Masuhiro
    Abe, Osamu
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 99 (04) : 1441 - 1453
  • [26] SV2A synaptic density imaging in the neonate rhesus macaque brain: Analysis with partial volume correction
    Rossano, Samantha
    Carson, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [27] Quantitative assessment of synaptic density using the SV2A ligand 11C-UCBA in humans
    Lubberink, M.
    Appel, L.
    Lindskog, K.
    Danfors, T.
    Sprycha, M.
    Daging, J.
    Eriksson, J.
    Larsson, E. -M.
    Kumlien, E.
    Antoni, G.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 74 - 74
  • [28] Voxel-wise estimation of nondisplaceable binding (VND) for PET SV2A synaptic density imaging with 11C-UCB-J
    Rossano, Samantha
    Carson, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [29] A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam
    Stockburger, Carola
    Miano, Davide
    Baeumlisberger, Marion
    Pallas, Thea
    Arrey, Tabiwang N.
    Karas, Michael
    Friedland, Kristina
    Mueller, Walter E.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (01) : 201 - 215
  • [30] Gray and white matter changes in Alzheimer's disease: A diffusion tensor imaging study
    Rose, Stephen E.
    Janke, Andrew L.
    Chalk, Jonathan B.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (01) : 20 - 26